Key Factors Contributing to Digital Health Innovation
15-Nov-2019
Global
Market Research
9AB9-00-A7-00-00
HC03234-GL-MR_23749
This report aims to highlight the potential of Israel in becoming one of the leading centres for digital health innovation, globally. The report also presents some of the innovative startups working in the digital health space, as an example of the country’s potential.
Research Scope
- Market trends (emission regulations/mandates, upcoming vehicle segment, hybrid/electric technologies and key partnerships)
- Regional trends (Europe, North America, China, Japan, and South Korea)
- Services, solution, strategy adoption, and technologies for specific segments such as passenger vehicles with crossover and SUV segments
- Highlights of key opportunities created by Tier I suppliers and vehicle manufacturers
The healthcare industry is attracting investment in many forms due to its ever-flourishing nature. Healthcare products and services will always be in demand and their need will continue to rise under the influence of demographic trends (like population ageing), epidemiological trends (rising incidence and complexity of chronic and infectious diseases), and economic trends (like growing middle class with higher knowledge, awareness, and affordability for high quality care). At the same time, healthcare spending needs to be optimized and quality of and access to care needs to be improved across many countries. To match future healthcare industry paradigms, innovation in healthcare is a necessity. Whether it is in the field of precision medicine, robotics, communication technologies, payment models, or care delivery services, healthcare startups, as well as innovation centres within established healthcare companies, are hard at work.
Several countries are setting up healthcare innovation hubs where diverse industry stakeholders can come together and create service ecosystems and marketplaces that allow the development of innovative start-ups. Healthcare innovation hubs focus on specific industry issues or sectors which are currently underserved but are likely to generate high revenue and employment if various industry participants (healthcare providers, payers, pharmaceuticals, medical technology vendors, start-ups, investors, universities and R&D centres) are given the opportunity to collaborate and create viable business models. On the surface, industry participants are encouraged to set up base in these innovation hubs through tax benefits and government-funded rewards. However, the advantages offered by innovation hubs do not end there. The most important contribution of an innovation hub is the pooling of skilled professionals that can positively contribute to industry development. In addition, governments also invest in developing peripheral infrastructure, such as roads, affordable housing, internet connectivity, utilities, and transportation in healthcare innovation hubs to further develop the ecosystem.
Frost & Sullivan analysed one of the most prominent emerging healthcare innovation centre—Israel. The base year for the study is 2018 and 2019 to 2023 is the forecast period. Israel was one of the earliest destinations for multinational technology giants like Apple and IBM for their R&D centres owing to the high quality and volume of engineering talent available in the country. The study provides key market drivers, trends, and challenges impacting the overall dynamics. It also provides an overview of the favorable government policies and ecosystem support, which has proved Israel to be a suitable location to set up R&D centres for healthcare businesses. Companies can use this location to develop their own innovations, partner with local Israeli companies to acquire new technologies and leverage this presence to consider expansion of specific solutions in the United States and Europe.
Key Issues Addressed
- What are the elements available in Israel’s ecosystem that are driving innovation to make it a competitive destination as a healthcare innovation hub?
- What are some of the existing examples of digital health startups and established healthcare companies in the region?
- What are the key innovation areas expected to propel the next stage of evolution in the digital health and healthcare delivery in the Israeli market?
- Why is Israel a preferred destination for research units of major corporations and emerging startups?
Author: Gagandeep Singh
Key Findings
Scope and Segmentation
Key Questions this Study will Answer
Strategic Imperatives for Market Participants
Overview—Israel
Overview—Healthcare Industry in Israel
Overview—Healthcare System Organization
Overview—Healthcare Provider Base
Overview—Presence of Other Industry Participants
Market Drivers
Drivers Explained
Drivers Explained (continued)
Market Restraints
Restraints Explained
Restraints Explained (continued)
Startup Company Profile—GlucoMe
Startup Company Profile—GlucoMe (continued)
Startup Company Profile—Clew Medical
Startup Company Profile—Clew Medical (continued)
Startup Company Profile—Nutrino
Startup Company Profile—Nutrino (continued)
Examples of Other Digital Health Startups in Israel
Key Areas of Innovation in Israel
Final Conclusions and Insights
Legal Disclaimer
List of Exhibits
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Speak directly with our analytics experts for tailored recommendations.
Recent related Digital Health research
06 Oct 2026 | Global | Technology Research
Trends in Laboratory Automation, Global, 2021–2025
This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metaboli...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Scope
- Market trends (emission regulations/mandates, upcoming vehicle segment, hybrid/electric technologies and key partnerships)
- Regional trends (Europe, North America, China, Japan, and South Korea)
- Services, solution, strategy adoption, and technologies for specific segments such as passenger vehicles with crossover and SUV segments
- Highlights of key opportunities created by Tier I suppliers and vehicle manufacturers
The healthcare industry is attracting investment in many forms due to its ever-flourishing nature. Healthcare products and services will always be in demand and their need will continue to rise under the influence of demographic trends (like population ageing), epidemiological trends (rising incidence and complexity of chronic and infectious diseases), and economic trends (like growing middle class with higher knowledge, awareness, and affordability for high quality care). At the same time, healthcare spending needs to be optimized and quality of and access to care needs to be improved across many countries. To match future healthcare industry paradigms, innovation in healthcare is a necessity. Whether it is in the field of precision medicine, robotics, communication technologies, payment models, or care delivery services, healthcare startups, as well as innovation centres within established healthcare companies, are hard at work.
Several countries are setting up healthcare innovation hubs where diverse industry stakeholders can come together and create service ecosystems and marketplaces that allow the development of innovative start-ups. Healthcare innovation hubs focus on specific industry issues or sectors which are currently underserved but are likely to generate high revenue and employment if various industry participants (healthcare providers, payers, pharmaceuticals, medical technology vendors, start-ups, investors, universities and R&D centres) are given the opportunity to collaborate and create viable business models. On the surface, industry participants are encouraged to set up base in these innovation hubs through tax benefits and government-funded rewards. However, the advantages offered by innovation hubs do not end there. The most important contribution of an innovation hub is the pooling of skilled professionals that can positively contribute to industry development. In addition, governments also invest in developing peripheral infrastructure, such as roads, affordable housing, internet connectivity, utilities, and transportation in healthcare innovation hubs to further develop the ecosystem.
Frost & Sullivan analysed one of the most prominent emerging healthcare innovation centre—Israel. The base year for the study is 2018 and 2019 to 2023 is the forecast period. Israel was one of the earliest destinations for multinational technology giants like Apple and IBM for their R&D centres owing to the high quality and volume of engineering talent available in the country. The study provides key market drivers, trends, and challenges impacting the overall dynamics. It also provides an overview of the favorable government policies and ecosystem support, which has proved Israel to be a suitable location to set up R&D centres for healthcare businesses. Companies can use this location to develop their own innovations, partner with local Israeli companies to acquire new technologies and leverage this presence to consider expansion of specific solutions in the United States and Europe.
Key Issues Addressed
- What are the elements available in Israel’s ecos
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Natasha Gulati |
| Industries | Healthcare |
| WIP Number | 9AB9-00-A7-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9612-B1,9837-B1 |
Innovation Profiling for Israel, 2018–2023
$1,500.00
Special Price $1,125.00 save 25 %